scispace - formally typeset
Y

Yoshiyasu Terao

Researcher at University of Shizuoka

Publications -  169
Citations -  2973

Yoshiyasu Terao is an academic researcher from University of Shizuoka. The author has contributed to research in topics: Enantioselective synthesis & 1,3-Dipolar cycloaddition. The author has an hindex of 29, co-authored 169 publications receiving 2813 citations.

Papers
More filters
Journal ArticleDOI

The contribution of azo dyes to the mutagenic activity of the Cristais River.

TL;DR: It is shown that these dyes contributed to the mutagenic activity found in the Cristais River environmental samples analyzed and are indirectly affecting the quality of the related drinking water.
Journal ArticleDOI

Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system.

TL;DR: It is demonstrated that chlorinated derivatives of NP, OP, and BPS, even if artificially produced during wastewater processing, were less estrogenic than their parent chemicals, known as endocrine disruptors.
Journal ArticleDOI

Identification and quantification of chlorinated bisphenol A in wastewater from wastepaper recycling plants.

TL;DR: Chlorinated derivatives of bisphenol A were detected in the final effluents of eight paper manufacturing plants in Shizuoka, Japan, where thermal paper and/or other printed paper is used as the raw material.
Journal ArticleDOI

Products of Aqueous Chlorination of 17β-Estradiol and Their Estrogenic Activities

TL;DR: The estrogenic activity potentially stemming from 17beta-estradiol (E2) in drinking water, using ESI-LC-MS was used to identify the products of its aqueous chlorination under the following conditions, appears to be induced mainly by 2,4-dichloro-E2 and 2,7alpha-methyloctahydroinden-5-one.
Journal ArticleDOI

Formation of chlorinated derivatives of bisphenol A in waste paper recycling plants and their estrogenic activities

TL;DR: The estrogenic activities of bisphenol A and its chlorinated derivatives were evaluated by an agonist assay using the yeast two-hybrid system with and without a metabolic activation test using rat liver S9.